Physiomics Signs Further Project Agreement With CellCentric
Physiomics Signs Further Project Agreement With CellCentric
Read moreMon, 23rd Dec 2019 08:33
Physiomics Signs Further Project Agreement With CellCentric
Read moreMerck Commits To Initial Contracts With Physiomics For 2020
Read more(Sharecast News) - Shares of Physiomics leapt on Friday after it signed up to a £250,000 tranche of projects with pharmaceutical giant Merck and said trading was in line with expectations.
Read morePhysiomics Achieves Record Annual Total Income And Narrows Loss
Read more(Alliance News) - Physiomics PLC on Tuesday said it traded in line with analyst expectations in its recently completed financial year.Shares in Physiomics were down 5.4% at 3.22 pence in to
Read more(Alliance News) - Medical prediction software developer Physiomics PLC said Monday it has signed an agreement with Nasdaq-listed biopharma firm Bicycle Therapeutics and research charity Cancer is
Read more(Sharecast News) - Cancer treatment technology provider Physiomics has been awarded a contract by Nasdaq-listed Bicycle Therapeutics, it announced on Friday.
Read moreLONDON (Alliance News) - Physiomics PLC on Tuesday said it has completed its Innovate UK grant project and created a tool that can use routine blood tests to determine drug dosages for prostate in
Read moreLONDON (Alliance News) - Physiomics PLC on Wednesday said it will use the opportunity of an upcoming conference to meet with current as well as potential future clients.Shares in the to the
Read moreLONDON (Alliance News) - Physiomics PLC on Thursday reported a narrowed loss for the first half of its current financial year, helped by strong revenue growth.The AIM-listed company, which
Read more(Sharecast News) - Physiomics on Thursday reported a narrowed interim loss after the cancer monitoring technology provider more than doubled its revenue over the period.
Read more(Sharecast News) - Physiomics announced on Monday that, following a successful collaboration and pursuant to the master services agreement signed with US pharmaceuticals giant Merck in November last year, it had agreed with a programme of work for the next calendar year.
Read moreLONDON (Alliance News) - Medical prediction software developer Physiomics PLC said Monday its full year loss halved as revenue doubled amid a "renewed" momentum at the firm.For to
Read more(Sharecast News) - Cancer treatment prediction technology developer Physiomics has been awarded a contract by a new European biotech client, it announced on Thursday.
Read more